CABA
Price
$1.71
Change
+$0.06 (+3.64%)
Updated
Aug 15 closing price
Capitalization
156.41M
86 days until earnings call
PYXS
Price
$1.23
Change
+$0.10 (+8.85%)
Updated
Aug 15 closing price
Capitalization
76.2M
92 days until earnings call
Interact to see
Advertisement

CABA vs PYXS

Header iconCABA vs PYXS Comparison
Open Charts CABA vs PYXSBanner chart's image
Cabaletta Bio
Price$1.71
Change+$0.06 (+3.64%)
Volume$1.25M
Capitalization156.41M
Pyxis Oncology
Price$1.23
Change+$0.10 (+8.85%)
Volume$676.64K
Capitalization76.2M
CABA vs PYXS Comparison Chart in %
Loading...
CABA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PYXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CABA vs. PYXS commentary
Aug 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CABA is a Hold and PYXS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 18, 2025
Stock price -- (CABA: $1.65 vs. PYXS: $1.23)
Brand notoriety: CABA and PYXS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CABA: 0% vs. PYXS: 127%
Market capitalization -- CABA: $156.41M vs. PYXS: $76.2M
CABA [@Biotechnology] is valued at $156.41M. PYXS’s [@Biotechnology] market capitalization is $76.2M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.71B to $0. The average market capitalization across the [@Biotechnology] industry is $1.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CABA’s FA Score shows that 1 FA rating(s) are green whilePYXS’s FA Score has 1 green FA rating(s).

  • CABA’s FA Score: 1 green, 4 red.
  • PYXS’s FA Score: 1 green, 4 red.
According to our system of comparison, both CABA and PYXS are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CABA’s TA Score shows that 6 TA indicator(s) are bullish while PYXS’s TA Score has 5 bullish TA indicator(s).

  • CABA’s TA Score: 6 bullish, 3 bearish.
  • PYXS’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, CABA is a better buy in the short-term than PYXS.

Price Growth

CABA (@Biotechnology) experienced а +21.32% price change this week, while PYXS (@Biotechnology) price change was +16.04% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.94%. For the same industry, the average monthly price growth was +21.39%, and the average quarterly price growth was +21.23%.

Reported Earning Dates

CABA is expected to report earnings on Nov 12, 2025.

PYXS is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Biotechnology (+5.94% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CABA($156M) has a higher market cap than PYXS($76.2M). PYXS YTD gains are higher at: -21.154 vs. CABA (-27.313). PYXS has higher annual earnings (EBITDA): -83.39M vs. CABA (-123.92M). CABA has more cash in the bank: 132M vs. PYXS (105M). PYXS has less debt than CABA: PYXS (19.8M) vs CABA (28.8M). CABA (0) and PYXS (0) have equivalent revenues.
CABAPYXSCABA / PYXS
Capitalization156M76.2M205%
EBITDA-123.92M-83.39M149%
Gain YTD-27.313-21.154129%
P/E RatioN/AN/A-
Revenue00-
Total Cash132M105M126%
Total Debt28.8M19.8M145%
TECHNICAL ANALYSIS
Technical Analysis
CABAPYXS
RSI
ODDS (%)
Bullish Trend 4 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
Momentum
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 4 days ago
82%
MACD
ODDS (%)
Bullish Trend 4 days ago
78%
Bullish Trend 4 days ago
84%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
86%
Bullish Trend 4 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
88%
Bullish Trend 4 days ago
88%
Advances
ODDS (%)
Bullish Trend 26 days ago
87%
Bullish Trend 4 days ago
81%
Declines
ODDS (%)
Bearish Trend 8 days ago
89%
Bearish Trend 8 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bearish Trend 4 days ago
88%
Bullish Trend 4 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
CABA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PYXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BOLSY7.270.12
+1.72%
B3 SA Brasil Bolsa Balcao
PRZFF0.09N/A
N/A
Boundary Gold & Copper Mng Ltd.
TRNGF0.03N/A
N/A
The Trendlines Group Ltd.
SECYF11.86-0.07
-0.58%
SECURE WASTE INFRASTRUCTURE CORP.
ABANF5.90-0.10
-1.67%
Automatic Bank Services Ltd.

CABA and

Correlation & Price change

A.I.dvisor indicates that over the last year, CABA has been loosely correlated with IPSC. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if CABA jumps, then IPSC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CABA
1D Price
Change %
CABA100%
N/A
IPSC - CABA
51%
Loosely correlated
+2.15%
GBIO - CABA
46%
Loosely correlated
-4.84%
KYTX - CABA
46%
Loosely correlated
-0.85%
PYXS - CABA
45%
Loosely correlated
+8.85%
RXRX - CABA
43%
Loosely correlated
+2.30%
More

PYXS and

Correlation & Price change

A.I.dvisor indicates that over the last year, PYXS has been loosely correlated with KURA. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if PYXS jumps, then KURA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PYXS
1D Price
Change %
PYXS100%
+8.85%
KURA - PYXS
64%
Loosely correlated
+11.21%
BEAM - PYXS
42%
Loosely correlated
+1.08%
RXRX - PYXS
41%
Loosely correlated
+2.30%
BLRX - PYXS
40%
Loosely correlated
-1.59%
SYRE - PYXS
39%
Loosely correlated
+0.53%
More